1-1-diphenyl-2-picrylhydrazyl and Lymphoma--T-Cell

1-1-diphenyl-2-picrylhydrazyl has been researched along with Lymphoma--T-Cell* in 1 studies

Other Studies

1 other study(ies) available for 1-1-diphenyl-2-picrylhydrazyl and Lymphoma--T-Cell

ArticleYear
Biosynthesis of silver nanoparticles: Elucidation of prospective mechanism and therapeutic potential.
    Journal of colloid and interface science, 2014, Feb-01, Volume: 415

    The synthesis of silver nanoparticles (AgNPs) was accomplished using Syzygium cumini fruit extract at room temperature. Various techniques were used to characterize the newly synthesized silver nanoparticles and their size was determined to be 10-15nm. Important findings of this study were the identification of biomolecules responsible for the synthesis of silver nanoparticles and elucidate the mechanism of biosynthesis. Flavonoids present in S. cumini were mainly responsible for the reduction and the stabilization of nanoparticles. The antioxidant properties of AgNPs were evaluated using various assays. The nanoparticles were also found to destroy Dalton lymphoma cell lines under in vitro condition. Silver nanoparticles (100μg/mL) decreased the viability of Dalton lymphoma (DL) cell lines up to 50%. The studies describing the biosynthesis of silver nanoparticles by fruit extract followed by the investigation of synthesis mechanism and anti-cancer activities may be useful for nanobiotechnology research opening a new arena in this field.

    Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Biphenyl Compounds; Cell Line, Tumor; Cell Survival; Flavonoids; Fruit; Humans; Inhibitory Concentration 50; Lymphoma, T-Cell; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Neoplasms, Experimental; Oxidation-Reduction; Picrates; Plant Extracts; Silver; Spectroscopy, Fourier Transform Infrared; Syzygium

2014